Given the ability of TTPAL to activate cholesterol biosynthesis, we explored whether TTPAL could serve as a novel therapeutic target for the inhibition of cholesterol biosynthesis in ESCC cells. The gene discussed is TTPAL; the disease is esophageal squamous cell carcinoma.